Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Gut Microbes. 2024 Jan-Dec;16(1):2374596. doi: 10.1080/19490976.2024.2374596. Epub 2024 Jul 18.
ABSTRACT
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer characterized by late diagnosis, rapid progression, and a high mortality rate. Its complex biology, characterized by a dense, stromal tumor environment with an immunosuppressive milieu, contributes to resistance against standard treatments like chemotherapy and radiation. This comprehensive review explores the dynamic role of the microbiome in modulating chemotherapy efficacy and outcomes in PDAC. It delves into the microbiome’s impact on drug metabolism and resistance, and the interaction between microbial elements, drugs, and human biology. We also highlight the significance of specific bacterial species and microbial enzymes in influencing drug action and the immune response in the tumor microenvironment. Cutting-edge methodologies, including artificial intelligence, low-biomass microbiome analysis and patient-derived organoid models, are discussed, offering insights into the nuanced interactions between microbes and cancer cells. The potential of microbiome-based interventions as adjuncts to conventional PDAC treatments are discussed, paving the way for personalized therapy approaches. This review synthesizes recent research to provide an in-depth understanding of how the microbiome affects chemotherapy efficacy. It focuses on elucidating key mechanisms and identifying existing knowledge gaps. Addressing these gaps is crucial for enhancing personalized medicine and refining cancer treatment strategies, ultimately improving patient outcomes.
PMID:39024520 | DOI:10.1080/19490976.2024.2374596
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
Microbiome and pancreatic cancer: time to think about chemotherapy
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
Dynamic Anthropometrics in Pancreatic Cancer: Associations Between Body Composition Changes During Neoadjuvant Therapy and Survival Outcomes After Resection Implications of microbe-derived ɣ-aminobutyric acid (GABA) in gut and brain barrier integrity and GABAergic signaling in Alzheimer's disease A powerful machine learning approach to identify interactions of differentially abundant gut microbial subsets in patients with metastatic and non-metastatic pancreatic cancer The early life exposome and autism risk: a role for the maternal microbiome? The Role of Diet and the Gut Microbiota in Reactive Aggression and Adult ADHD-An Exploratory Analysis Influence of human gut microbiome on the healthy and the neurodegenerative aging Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade Chronic binge drinking-induced susceptibility to colonic inflammation is microbiome-dependent Meta-analysis of the human gut microbiome uncovers shared and distinct microbial signatures between diseases Drug repurposing for cancer Drug repurposing for cancer The interplay between mitochondria, the gut microbiome and metabolites and their therapeutic potential in primary mitochondrial disease Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-naïve patients with pancreatic ductal adenocarcinoma Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-naïve patients with pancreatic ductal adenocarcinoma Changes in Psychological Condition during Cancer Chemotherapy Glycolysis and chemoresistance in acute myeloid leukemia Glycolysis and chemoresistance in acute myeloid leukemia Altered Mental Status in Cancer Modulation of Gut Microbiome and Autism Symptoms of ASD Children Supplemented with Biological Response Modifier: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study Modulation of Gut Microbiome and Autism Symptoms of ASD Children Supplemented with Biological Response Modifier: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study Deciphering tertiary lymphoid structure heterogeneity reveals prognostic signature and therapeutic potentials for colorectal cancer: a multicenter retrospective cohort study A Fibroblast activation protein α-activatable nanoagent co-delivering diethyldithiocarbamate and copper for tumor therapy and imaging Involvement of the gut microbiome-brain axis in alcohol use disorder Association between the oral microbiome and brain resting state connectivity in schizophrenia Mapping the Geographical Distribution of the Mucosa-Associated Gut Microbiome in GI-Symptomatic Children with Autism Spectrum Disorder Microbiome signature of posttraumatic stress disorder and resilience in youth Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications PERIOPERATIVE CHEMOTHERAPY, ADJUVANT CHEMOTHERAPY AND ADJUVANT CHEMORADIOTHERAPY IN THE SURGICAL TREATMENT OF GASTRIC CANCER IN A HOSPITAL OF THE BRAZILIAN UNIFIED HEALTH SYSTEM Modulation of Alzheimer's disease brain pathology in mice by gut bacterial depletion: the role of IL-17a 3D bioprinting of an in vitro hepatoma microenvironment model: establishment, evaluation, and anticancer drug testing Quinic acid alleviates high-fat diet-induced neuroinflammation by inhibiting DR3/IKK/NF-κB signaling via gut microbial tryptophan metabolites Longitudinal microbiome investigation throughout prion disease course reveals pre- and symptomatic compositional perturbations linked to short-chain fatty acid metabolism and cognitive impairment in mice Longitudinal microbiome investigation throughout prion disease course reveals pre- and symptomatic compositional perturbations linked to short-chain fatty acid metabolism and cognitive impairment in mice Neurodevelopmental implications of COVID-19-induced gut microbiome dysbiosis in pregnant women Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy Persistence and Sexual Dimorphism of Gut Dysbiosis and Pathobiome after Sepsis and Trauma The atypical antipsychotics lurasidone and olanzapine exert contrasting effects on the gut microbiome and metabolic function of rats Gut microbial diversity and functional characterization in people with alcohol use disorder: A case-control study Relationships between the gut microbiome and brain functional alterations in first-episode, drug-naive patients with major depressive disorder Oral microbiota in autistic children: Diagnosis-related differences and associations with clinical characteristics Time-restricted feeding ameliorates non-alcoholic fatty liver disease through modulating hepatic nicotinamide metabolism via gut microbiota remodeling Treatment of Locally Advanced Rectal Cancer in the Era of Total Neoadjuvant Therapy: A Systematic Review and Network Meta-Analysis Premodulator microbiome alterations associated with postmodulator growth outcomes in pediatric cystic fibrosis: Can we predict outcomes? Premodulator microbiome alterations associated with postmodulator growth outcomes in pediatric cystic fibrosis: Can we predict outcomes? Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease Gut microbiota-astrocyte axis: new insights into age-related cognitive decline Measurement of Cognitive Function in Exercise Oncology Studies in Patients Treated With Chemotherapy: A Scoping Review Absence of association between maternal adverse events and long-term gut microbiome outcomes in the Australian autism biobank Multiple aspects of matrix stiffness in cancer progression Molecular and epigenetic ex vivo profiling of testis cancer-associated fibroblasts and their interaction with germ cell tumor cells and macrophages Current landscape of fecal microbiota transplantation in treating depression Exploring the gut-brain Axis: Potential therapeutic impact of Psychobiotics on mental health Reproducible gut microbial signatures in bipolar and schizophrenia spectrum disorders: A metagenome-wide study Reproducible gut microbial signatures in bipolar and schizophrenia spectrum disorders: A metagenome-wide study Serum bile acids profiles are altered without change of the gut microbiota composition following a seven-day prednisolone therapy in severe alcoholic hepatitis Unravelling the tumor microenvironment of gastric cancer peritoneal metastase Application of omics in the diagnosis, prognosis, and treatment of acute myeloid leukemia Gut microbiome and major depressive disorder: insights from two-sample Mendelian randomization The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC Inhibition of the sterol regulatory element binding protein (SREB-P) SREBF-1 overcomes docetaxel resistance in advanced prostate cancer Washed microbiota transplantation promotes homing of group 3 innate lymphoid cells to the liver via the CXCL16/CXCR6 axis: a potential treatment for metabolic-associated fatty liver disease
Evidence Blueprint
Microbiome and pancreatic cancer: time to think about chemotherapy
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Microbiome and pancreatic cancer: time to think about chemotherapy
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities Exploiting pancreatic cancer metabolism: challenges and opportunities Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD) Dynamic Anthropometrics in Pancreatic Cancer: Associations Between Body Composition Changes During Neoadjuvant Therapy and Survival Outcomes After Resection Longitudinal analysis of the gut microbiome in adolescent patients with anorexia nervosa: microbiome-related factors associated with clinical outcome BEYOND TRADITIONAL TOOLS: EXPLORING CONVOLUTIONAL NEURAL NETWORKS AS INNOVATIVE PROGNOSTIC MODELS IN PANCREATIC DUCTAL ADENOCARCINOMA Early detection of pancreatic cancer in the era of precision medicine Implications of microbe-derived ɣ-aminobutyric acid (GABA) in gut and brain barrier integrity and GABAergic signaling in Alzheimer's disease A comprehensive review on the pharmacological role of gut microbiome in neurodegenerative disorders: potential therapeutic targets A powerful machine learning approach to identify interactions of differentially abundant gut microbial subsets in patients with metastatic and non-metastatic pancreatic cancer pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model Long-term recurrence-free survival following pancreatic surgery with HIPEC treatment for locally advanced pancreatic adenocarcinoma The early life exposome and autism risk: a role for the maternal microbiome? Association of homelessness and diet on the gut microbiome: a United States-Veteran Microbiome Project (US-VMP) study The Role of Diet and the Gut Microbiota in Reactive Aggression and Adult ADHD-An Exploratory Analysis A metagenome-wide association study of gut microbiome in patients with AMD, ASD, RA, T2D & VKH diseases Influence of human gut microbiome on the healthy and the neurodegenerative aging Emulation and evaluation of tumor cell combined chemotherapy in isotropic/anisotropic collagen fiber microenvironments Emulation and evaluation of tumor cell combined chemotherapy in isotropic/anisotropic collagen fiber microenvironments Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside Exercise and the gut microbiome: implications for supportive care in cancer Mood disorders: the gut bacteriome and beyond Chronic binge drinking-induced susceptibility to colonic inflammation is microbiome-dependent A Comprehensive Overview on Chemotherapy-Induced Cardiotoxicity: Insights into the Underlying Inflammatory and Oxidative Mechanisms Meta-analysis of the human gut microbiome uncovers shared and distinct microbial signatures between diseases Gut commensal Kineothrix alysoides mitigates liver dysfunction by restoring lipid metabolism and gut microbial balance From gut microbiota to brain: implications on binge eating disorders Drug repurposing for cancer Drug repurposing for cancer Correlation between human gut microbiome and diseases The interplay between mitochondria, the gut microbiome and metabolites and their therapeutic potential in primary mitochondrial disease Nurturing development: how a mother's nutrition shapes offspring's brain through the gut Fiber deprivation and microbiome-borne curli shift gut bacterial populations and accelerate disease in a mouse model of Parkinson's disease Can we manage gut microbiome imbalances in patients with bipolar disorder with pharmacotherapy? Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-naïve patients with pancreatic ductal adenocarcinoma Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-naïve patients with pancreatic ductal adenocarcinoma The emerging role of the gut microbiome in posttraumatic stress disorder Resistance to anti-EGFR through the successive and cumulative acquisition of two new oncogenic addictions: BRAF and ALK Cancer associated fibroblasts modulate the cytotoxicity of anti-cancer drugs in breast cancer: An in vitro study Cultivated Enterococcus faecium B6 from children with obesity promotes nonalcoholic fatty liver disease by the bioactive metabolite tyramine Relationships among the gut microbiome, brain networks, and symptom severity in schizophrenia patients: A mediation analysis 13C-Stable isotope resolved metabolomics uncovers dynamic biochemical landscape of gut microbiome-host organ communications in mice Gut-microbiota prompt activation of natural killer cell on alcoholic liver disease Signal enhancement ratio of multi-phase contrast-enhanced MRI: an imaging biomarker for survival in pancreatic adenocarcinoma Changes in Psychological Condition during Cancer Chemotherapy Between Dysbiosis, Maternal Immune Activation and Autism: Is There a Common Pathway? Glycolysis and chemoresistance in acute myeloid leukemia Glycolysis and chemoresistance in acute myeloid leukemia The Microbiome in Child and Adolescent Psychiatry Altered Mental Status in Cancer A Randomized Trial of Two Remote Healthcare Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing… Modulation of Gut Microbiome and Autism Symptoms of ASD Children Supplemented with Biological Response Modifier: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study Modulation of Gut Microbiome and Autism Symptoms of ASD Children Supplemented with Biological Response Modifier: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study Peripheral neuronal activation shapes the microbiome and alters gut physiology Associations of the Gut Microbiome With Treatment Resistance in Schizophrenia Chemobrain: An accelerated aging process linking adenosine A2A receptor signaling in cancer survivors Deciphering tertiary lymphoid structure heterogeneity reveals prognostic signature and therapeutic potentials for colorectal cancer: a multicenter retrospective cohort study Deciphering the therapeutic potential of SheXiangXinTongNing: Interplay between gut microbiota and brain metabolomics in a CUMS mice model, with a focus on tryptophan metabolism Deciphering the therapeutic potential of SheXiangXinTongNing: Interplay between gut microbiota and brain metabolomics in a CUMS mice model, with a focus on tryptophan metabolism Research progress on ferroptosis in gliomas (Review)